Quoin Pharmaceuticals shares are trading higher after the company announced FDA clearance to recruit teen subjects into both of its ongoing Netherton Syndrome clinical studies.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.